Background-The efficacy of granulocyte colony-stimulating factor (G-CSF) for coronary collateral growth promotion and thus impending myocardial salvage has not been studied so far, to our best knowledge. Methods and Results-In 52 patients with chronic stable coronary artery disease, age 62Ϯ11 years, the effect on a marker of myocardial infarct size (ECG ST segment elevation) and on quantitative collateral function during a 1-minute coronary balloon occlusion was tested in a randomized, placebo-controlled, double-blind fashion. The study protocol before coronary intervention consisted of occlusive surface and intracoronary lead ECG recording as well as collateral flow index (CFI, no unit) measurement in a stenotic and a Ն1 normal coronary artery before and after a 2-week period with subcutaneous G-CSF (10 g/kg; nϭ26) or placebo (nϭ26). The CFI was determined by simultaneous measurement of mean aortic, distal coronary occlusive, and central venous pressure. The ECG ST segment elevation Ͼ0.1 mV disappeared significantly more often in response to G-CSF (11/53 vessels; 21%) than to placebo (0/55 vessels; Pϭ0.0005), and simultaneously, CFI changed from 0.121Ϯ0.087 at baseline to 0.166Ϯ0.086 at follow-up in the G-CSF group, and from 0.152Ϯ0.082 to 0.131Ϯ0.071 in the placebo group (PϽ0.0001 for interaction of treatment and time). The absolute change in CFI from baseline to follow-up amounted to ϩ0.049Ϯ0.062 in the G-CSF group and to Ϫ0.010Ϯ0.060 in the placebo group (PϽ0.0001).
Conclusions-Subcutaneous